Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

P-glycoprotein, but not multidrug resistance protein 4, plays a role in the systemic clearance of irinotecan and SN-38 in mice.

Tagen M, Zhuang Y, Zhang F, Harstead KE, Shen J, Schaiquevich P, Fraga CH, Panetta JC, Waters CM, Stewart CF.

Drug Metab Lett. 2010 Dec;4(4):195-201.

2.

Determination of dopamine, serotonin, and their metabolites in pediatric cerebrospinal fluid by isocratic high performance liquid chromatography coupled with electrochemical detection.

Hubbard KE, Wells A, Owens TS, Tagen M, Fraga CH, Stewart CF.

Biomed Chromatogr. 2010 Jun;24(6):626-31. doi: 10.1002/bmc.1338.

PMID:
19810006
3.

Simultaneous determination of cyclophosphamide and carboxyethylphosphoramide mustard in human plasma using online extraction and electrospray tandem mass spectrometry (HTLC-ESI-MS/MS).

Bai F, Fraga CH, Tagen M, Schaiquevich P, Hagedorn N, Stewart CF.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jun 15;877(18-19):1709-15. doi: 10.1016/j.jchromb.2009.04.025. Epub 2009 Apr 24.

4.

Expression of the multi-drug resistance proteins and the pregnane X receptor in treated and untreated retinoblastoma.

Wilson MW, Fraga CH, Rodriguez-Galindo C, Hagedorn N, Leggas ML, Stewart C.

Curr Eye Res. 2009 May;34(5):386-94. doi: 10.1080/02713680902859621.

PMID:
19401882
5.

Application of a highly specific and sensitive fluorescent HPLC method for topotecan lactone in whole blood.

Hubbard KE, Schaiquevich P, Bai F, Fraga CH, Miller L, Panetta JC, Stewart CF.

Biomed Chromatogr. 2009 Jul;23(7):707-13. doi: 10.1002/bmc.1173.

6.

Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy.

Dickson PV, Hamner JB, Sims TL, Fraga CH, Ng CY, Rajasekeran S, Hagedorn NL, McCarville MB, Stewart CF, Davidoff AM.

Clin Cancer Res. 2007 Jul 1;13(13):3942-50.

7.

UGT1A1 promoter genotype correlates with SN-38 pharmacokinetics, but not severe toxicity in patients receiving low-dose irinotecan.

Stewart CF, Panetta JC, O'Shaughnessy MA, Throm SL, Fraga CH, Owens T, Liu T, Billups C, Rodriguez-Galindo C, Gajjar A, Furman WL, McGregor LM.

J Clin Oncol. 2007 Jun 20;25(18):2594-600.

PMID:
17577039
8.

Determination of Cloretazine (VNP40101M) and its active metabolite (VNP4090CE) in human plasma by liquid chromatography electrospray tandem mass spectrometry (LC-ESI-MS/MS).

Bai F, Minkin P, Fraga CH, O'Shaughnessy MA, Gururangan S, Stewart CF.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 15;853(1-2):97-104. Epub 2007 Mar 24.

PMID:
17446145
9.

Interferon beta-mediated vessel stabilization improves delivery and efficacy of systemically administered topotecan in a murine neuroblastoma model.

Dickson PV, Hagedorn NL, Hamner JB, Fraga CH, Ng CY, Stewart CF, Davidoff AM.

J Pediatr Surg. 2007 Jan;42(1):160-5; discussion 165.

PMID:
17208558
10.

Topotecan central nervous system penetration is altered by a tyrosine kinase inhibitor.

Zhuang Y, Fraga CH, Hubbard KE, Hagedorn N, Panetta JC, Waters CM, Stewart CF.

Cancer Res. 2006 Dec 1;66(23):11305-13.

11.

Immunohistochemical detection of multidrug-resistant protein expression in retinoblastoma treated by primary enucleation.

Wilson MW, Fraga CH, Fuller CE, Rodriguez-Galindo C, Mancini J, Hagedorn N, Leggas ML, Stewart CF.

Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1269-73.

PMID:
16565357
12.

Determination of lapatinib (GW572016) in human plasma by liquid chromatography electrospray tandem mass spectrometry (LC-ESI-MS/MS).

Bai F, Freeman BB 3rd, Fraga CH, Fouladi M, Stewart CF.

J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Feb 2;831(1-2):169-75. Epub 2005 Dec 20.

PMID:
16364699
13.

Increased expression of vascular endothelial growth factor messenger RNA in lungs of rats after cavopulmonary anastomosis.

Mumtaz MA, Fraga CH, Nicholls CM, Desai S, Vasilyev N, Joshi R, Mee RB, Duncan BW.

J Thorac Cardiovasc Surg. 2005 Jan;129(1):209-10. No abstract available.

14.

Poly (ADP) ribose synthetase inhibition reduces obliterative airway disease in rat tracheal allografts.

Farivar AS, Woolley SM, Naidu BV, Fraga CH, Byrne K, Thomas R, Salzman AL, Szabo CS, Mulligan MS.

J Heart Lung Transplant. 2004 Aug;23(8):993-1002.

PMID:
15312830
15.

Intratracheal poly (ADP) ribose synthetase inhibition ameliorates lung ischemia reperfusion injury.

Farivar AS, Woolley SM, Fraga CH, Thomas R, Salzman AL, Szabo C, Mulligan MS.

Ann Thorac Surg. 2004 Jun;77(6):1938-43.

PMID:
15172241
16.

Early tumor necrosis factor-alpha release from the pulmonary macrophage in lung ischemia-reperfusion injury.

Naidu BV, Woolley SM, Farivar AS, Thomas R, Fraga CH, Goss CH, Mulligan MS.

J Thorac Cardiovasc Surg. 2004 May;127(5):1502-8.

17.

Beta-chemokine function in experimental lung ischemia-reperfusion injury.

Krishnadasan B, Farivar AS, Naidu BV, Woolley SM, Byrne K, Fraga CH, Mulligan MS.

Ann Thorac Surg. 2004 Mar;77(3):1056-62.

PMID:
14992926
18.

Proinflammatory response of alveolar type II pneumocytes to in vitro hypoxia and reoxygenation.

Farivar AS, Woolley SM, Fraga CH, Byrne K, Mulligan MS.

Am J Transplant. 2004 Mar;4(3):346-51.

19.

Rat model of pulmonary arteriovenous malformations after right superior cavopulmonary anastomosis.

Starnes SL, Duncan BW, Fraga CH, Desai SY, Jones TK, Mathur SK, Rosenthal GL, Lupinetti FM.

Am J Physiol Heart Circ Physiol. 2002 Nov;283(5):H2151-6.

20.

Angiogenic proteins in the lungs of children after cavopulmonary anastomosis.

Starnes SL, Duncan BW, Kneebone JM, Rosenthal GL, Patterson K, Fraga CH, Kilian KM, Mathur SK, Lupinetti FM.

J Thorac Cardiovasc Surg. 2001 Sep;122(3):518-23.

21.

Pulmonary microvessel density is a marker of angiogenesis in children after cavopulmonary anastomosis.

Starnes SL, Duncan BW, Kneebone JM, Fraga CH, States S, Rosenthal GL, Lupinetti FM.

J Thorac Cardiovasc Surg. 2000 Nov;120(5):902-7.

22.

Supplemental Content

Loading ...
Support Center